Thomas Münzel, Alexandra Schneider, Andreas Daiber
{"title":"[Climate and the Heart].","authors":"Thomas Münzel, Alexandra Schneider, Andreas Daiber","doi":"10.1055/a-2420-6262","DOIUrl":"10.1055/a-2420-6262","url":null,"abstract":"<p><p>Climate change is the greatest existential threat to planetary and human health, driven by shifts in the Earth's weather and atmospheric conditions due to human activities. It causes extreme temperatures, increased droughts, wildfires, dust storms, coastal flooding, storm surges, hurricanes, and various compounded events. The impacts of climate change on health are complex and include pathways that contribute to non-communicable diseases like cardiovascular disease. A collaborative effort among medical professionals, researchers, public health officials, and policymakers is crucial to mitigate the effects of global warming. This review provides an overview of how climate change affects cardiovascular health through direct exposures like temperature changes, air pollution, wildfires, dust storms, and extreme weather conditions. We also identify vulnerable populations and suggest mitigation strategies.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 17","pages":"1034-1039"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144801297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Antibiotic Stewardship in Nosocomial Pneumonia].","authors":"Irit Nachtigall, Jessica Rademacher, Evelyn Kramme","doi":"10.1055/a-2337-3496","DOIUrl":"10.1055/a-2337-3496","url":null,"abstract":"<p><p>Pneumonia is one of the most important nosocomially acquired infections in Germany. Rational management strategies contribute to optimizing treatment and minimizing the development of resistance. The calculated antimicrobial therapy should take into account the severity, the risk of multi-resistant pathogens and <i>P. aeruginosa</i> as well as the local resistance situation. The infection occurs more frequently in non-ventilated patients, yet the evidence for ventilator-associated pneumonia is better, mainly due to easier microbiological diagnostics. The spectrum of pathogens does not differ significantly between the two disease entities. <i>E. coli, K. pneumoniae, P. aeruginosa</i> and, in the gram-positive spectrum, <i>S. aureus</i> and <i>S. pneumoniae</i> are the most common pathogens detected. Early detection, particularly in sepsis, followed by targeted diagnostic measures are relevant managing the disease. Calculated antibiotic therapy taking into account the severity of the disease and the patient's individual risk of multi-resistant pathogens, should be administered promptly. A re-evaluation of the diagnosis and therapy after 48-72 hours is crucial for the success of treatment and the rational use of antibiotics. All findings obtained to confirm the diagnosis and assess the course of the disease should be reviewed with regard to the accuracy of the diagnosis, the therapeutic response and the possibility of optimizing antibiotic therapy. If there is a response to treatment, which is primarily expressed in a clinical improvement, the recommended treatment duration of 7 days should not be exceeded. If there is no improvement in symptoms, microbiological findings, complications and differential diagnoses should be checked. Pharmacokinetic and pharmacodynamic principles should be considered with regard to the substances and the duration of application and dosage.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 16","pages":"980-990"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144791117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[58-year-old patient with rheumatoid arthritis and leg edema].","authors":"Luisa Schneider, Jörg Henes, Andreas Goldschmied","doi":"10.1055/a-2594-1956","DOIUrl":"https://doi.org/10.1055/a-2594-1956","url":null,"abstract":"","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 17","pages":"1003-1004"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144801293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julian Philipp Kionke, Valentina Laura Müller, Alexander Kreuter
{"title":"[74-year-old patient with dermatological findings on the shaft of the penis].","authors":"Julian Philipp Kionke, Valentina Laura Müller, Alexander Kreuter","doi":"10.1055/a-2555-8919","DOIUrl":"https://doi.org/10.1055/a-2555-8919","url":null,"abstract":"","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 16","pages":"935-936"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144791116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Proportion of women on the executive boards and committees of 183 professional associations of the Association of the Scientific Medical Societies in Germany (AWMF)].","authors":"Uwe Janssens, Louisa Jahnke, Teresa Deffner, Monika Nothacker, Florian Hoffmann","doi":"10.1055/a-2618-0902","DOIUrl":"10.1055/a-2618-0902","url":null,"abstract":"<p><p>The growing proportion of women in medical studentship and medical practice contrasts with their under-represented role in leadership positions in medical professional associations in Germany. Against this background, the proportion of women in top positions of medical professional associations in Germany has been analysed.A total of 1460 individuals were counted in the analysis of the composition of the boards/presidia of the 183 professional societies. The proportion of women on the boards/executive committees was 32.6%. Of the 183 professional societies, 47 (25.7%) were led by a woman as president. 72 (39.3%) women served as vice presidents. Only 39 (21.3%) professional societies had a proportion of women on the boards/executive committees ≥50%.There is a significant imbalance of female leadership positions in medical professional associations in Germany. To address this inequality, a strategy with multiple initiatives is needed that includes both career development programmes such as mentoring and the design of congress participation to ensure a balanced gender representation.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 15","pages":"899-904"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144683888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kai Martin Jahns, Matthias Dreher, Konstantinos Triantafyllias, Lennart Haßdenteufel, Andreas Schwarting
{"title":"[From renal crisis to lung fibrosis - systemic sclerosis in the course of time].","authors":"Kai Martin Jahns, Matthias Dreher, Konstantinos Triantafyllias, Lennart Haßdenteufel, Andreas Schwarting","doi":"10.1055/a-2615-9127","DOIUrl":"10.1055/a-2615-9127","url":null,"abstract":"<p><p>Systemic sclerosis (SSc) is a connective tissue disease of multifactorial origin in which autoimmune inflammatory reactions lead to fibrosis of multiple tissues. In the past, renal crisis was a common complication with a very high mortality. Due to the recommendation for a more cautious use of corticosteroids and the use of ACE inhibitors as an acute treatment reduced the incidence of a renal crisis and improved overall survival since the 1980s. However, lung involvement including pulmonary arterial hypertension, interstitial lung disease and lung fibrosis is now the most common cause of death in SSc. An early detection, including the use of HR-CT screening, and adequate treatment of interstitial lung disease are therefore of the utmost importance. Mycophenolate mofetil (MMF) has proven to be an effective therapeutic agent for the pulmonary manifestation. Nintedanib is the only drug approved in Germany for SSc-associated progressive lung fibrosis. Studies have shown the best prognostic improvements with early combination therapy of MMF in combination with Nintedanib.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 16","pages":"975-979"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144791120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Acute pancreatitis: Progress through Restraint?]","authors":"Jonathan Frederik Brozat, Frank Tacke","doi":"10.1055/a-2286-0469","DOIUrl":"10.1055/a-2286-0469","url":null,"abstract":"<p><p>Acute pancreatitis (AP) is a potentially life-threatening disease, often progressing in 2 phases: initial sterile inflammation, followed by later infected necrosis. Advances in care have shifted management toward a minimally invasive, step-up approach. AP is diagnosed based on typical abdominal pain, elevated lipase, or characteristic imaging - amylase is no longer essential. In hypertriglyceridemic AP, plasmapheresis offers no proven benefit. (Endo)sonography is mandatory. Contrast-enhanced CT should be delayed unless necrosis is suspected or diagnosis remains uncertain; optimal timing is ≥72h, ideally after 7 days. Prognostic tools (BISAP, Ranson) and markers (hematocrit, lactate, BUN) are insufficient to predict severe or necrotizing AP. Post-hoc, the revised Atlanta classification may be more effective than the determinant-based classification. Emergency ERC (<24h) is only warranted in cholangitis. Without cholangitis, ERC within 72h is adequate; biliary sphincterotomy and pancreatic stenting reduce post-ERC pancreatitis. Opioids are superior to NSAIDs and are first-line for analgesia. Early, goal-directed fluid resuscitation with balanced crystalloids improves outcomes, while excessive fluids (>3mL/kg/h) should be avoided. Enteral/oral nutrition within 24h reduces the risk of infected necrosis and is preferred over parenteral feeding. Antibiotic prophylaxis is not recommended, even in necrotizing AP; infected necrosis is rare in the first 2 weeks. Procalcitonin may support therapeutic decisions. Necrosis should be managed stepwise: antibiotics, then drainage, then delayed minimally-invasive necrosectomy. Endoscopic access is preferred; open surgery is obsolete. Outcomes improve significantly in specialized, high-volume centers with critical care, interventional endoscopy/radiology, and pancreatic surgery expertise.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 17","pages":"1027-1033"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144801295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Charlotte Schwicht, Michael von Bergwelt-Baildon, Karsten Spiekermann
{"title":"[Immunosuppression in Cancer: Strategies for Infection Prevention].","authors":"Charlotte Schwicht, Michael von Bergwelt-Baildon, Karsten Spiekermann","doi":"10.1055/a-2414-8494","DOIUrl":"10.1055/a-2414-8494","url":null,"abstract":"<p><p>Antimicrobial prophylaxis is an important cornerstone for reducing morbidity and mortality of cancer patients. Important strides have been made in recent years in vaccination, drug prophylaxes and the use of growth-factor support. We detail these changes to the respective recommendations here.Patients with malignant disease are recommended to receive vaccinations against common respiratory pathogens (COVID-19, influenza, pneumococci, and RSV). For both influenza (now trivalent vaccine) and pneumococci (now PCV20), the preferred vaccine has changed. A VZV vaccination using an inactivated virus-subunit is also recommended to prevent reactivations. The profound B-cell depletion caused by CAR-T cell therapy is increasingly being considered in vaccination recommendations.In high-risk situations, antibiotic prophylaxis using fluoroquinolones can be used. However, due to increasing resistance and significant side effects, this approach is being critically evaluated.Posaconazole is recommended as the standard prophylaxis for patients with neutropenia >7 days (<0,5G/L) and hematologic malignancies. Isavuconazole offers an effective alternative for patients who cannot tolerate posaconazole. Interactions between antifungal agents and oncological therapies are becoming increasingly relevant, with particular attention to the CYP-450-enzyme inducing/inhibiting substances. Non-pharmacological measures to prevent fungal infections are now part of the recommendations. These include smoking cessation.Pharmacological prophylaxis for COVID-19 is generally not recommended.The thresholds for primary growth-factor-support have been lowered: G-CSF is generally recommended if the risk of febrile neutropenia is >20%, or, if patient inherent risk factors are present, >10%. A new long-acting, non-PEG-containing G-CSF preparation was approved in 2024.Good collaboration between oncologists and general practitioners is essential to translate these recommendations into clinical practice.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 17","pages":"1013-1018"},"PeriodicalIF":0.7,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144801300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Adrenal Crisis].","authors":"Dirk Weismann","doi":"10.1055/a-2318-7541","DOIUrl":"10.1055/a-2318-7541","url":null,"abstract":"<p><p>According to long-term studies, patients with adrenal insufficiency (AI) exhibit a reduced quality of life and increased mortality. In addition to cardiovascular and malignant diseases, the risk of mortality is particularly increased by adrenal crises. Fatal adrenal crises could be completely prevented by timely intravenous or subcutaneous administration of glucocorticoids. In the case of an established diagnosis of AI, a deterioration in the general condition, gastroenteritis symptoms, exsiccosis and a clinical picture of sepsis must lead to the suspicion of an adrenal crisis. However, the diagnosis is only confirmed by the response to glucocorticoids. So-called check-point inhibitors are becoming increasingly important as a cause of AI. Therefore, AI and adrenal crises continue to pose a challenge for patients, their relatives and the treating physicians.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 15","pages":"865-872"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144683884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}